Definite | $10,000,000 | (Aug 22, 2025)
WALLROUND | $4,873,008 | (Aug 22, 2025)
Method AI | $20,000,000 | (Aug 22, 2025)
Certified by Founder
Lodge
Dispatch Bio
start up
- 24/07/2025
- Series A
- Undisclosed Amount
Established in 2022, Dispatch Bio was founded with a bold purpose: to help create a world where all cancer patients can be cured. To achieve this, the company is engineering a universal treatment across solid tumors, leveraging its first-in-class Flare platform. This novel approach combines the strengths of immunotherapy with a tumor-specific viral vector, both engineered to clear tumor cells with precision and power. Dispatch has operations in Philadelphia and San Francisco, with access to world-class researchers.
- Industry Biotechnology Research
- Website https://dispatchbio.com/
- LinkedIn https://www.linkedin.com/company/dispatch-bio/
Therm | $3,600,000 | (Aug 22, 2025)
SugaROx | $1,341,635 | (Aug 22, 2025)
Molecular You | $5,000,000 | (Aug 22, 2025)
Verdata | $8,000,000 | (Aug 22, 2025)
Agenda Hero | $5,600,000 | (Aug 22, 2025)
The Better Meat Co. | $31,000,000 | (Aug 22, 2025)
CLIKA Inc. | Undisclosed Amount | (Aug 22, 2025)
Grid Aero | $6,000,000 | (Aug 22, 2025)
CVector | $1,500,000 | (Aug 22, 2025)